Trade Humacyte, Inc. - HUMA CFD

Trading Conditions

• Type: CFD
• Spread: 0.05
• Long position overnight funding adjustment: -0.02149%
• Short position overnight funding adjustment: -0.00074%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 0.83
• Open: 0.82
• 1-Year Change: -75.08%
• Day's Range: 0.75 - 0.82

What is Humacyte, Inc. (HUMA)?

Humacyte, Inc. is a biotechnology company engaged in the development of bioengineered human tissues for medical applications. The company focuses on creating off-the-shelf, regenerative tissue products designed to improve outcomes for patients with vascular and other tissue-related conditions. Its proprietary technology involves the use of human cells to produce acellular tissue grafts that can be implanted without the need for immunosuppressive therapy. These products aim to address unmet medical needs in areas such as vascular access for dialysis patients and peripheral arterial disease. The company operates within the regenerative medicine sector, combining tissue engineering and cellular biology to develop innovative therapeutic solutions.

Humacyte, Inc. Stock Price Today: Live Overview

The price today is shaped by fluctuations in Humacyte, Inc., with the live price at $0.82. The stock has moved within the range of $0.75 to $0.83, showing a daily price change of -4.878%.

FAQ: Humacyte, Inc. (HUMA)

What is the current price of HUMA stock?

The current price is $0.82.

Does HUMA pay dividends?

Humacyte, Inc. does not pay dividends.

Does HUMA have a formal corporate presence or regional headquarters in the UAE?

The company operates via partners in the UAE and does not have an official regional office or subsidiary.

What is HUMA best known for?

It is most famous for developing bioengineered blood vessels.

What assets are typically shown together with HUMA?

Commonly shown alongside HUMA: Lindblad Expeditions Holdings Inc, Enterprise Products Partners LP (USA), McEwen Inc